Skip to main content
. 2020 Jun 30;14(5):828–841. doi: 10.1007/s12072-020-10068-4

Fig. 4.

Fig. 4

p53 silencing ameliorates NAFLD symptoms in vitro. a Intracellular triglyceride levels and b ORO staining of PA-treated primary hepatocytes from p53+/+ and p53−/− mice (× 200). c Intracellular triglyceride levels and d ORO staining of p53-silenced HepG2 cells treated with PA (× 200). e Intracellular triglyceride levels and f ORO staining of p53-silenced Huh7 cells treated with different concentrations of PA for 24 h (× 100). *p < 0.05; NS no significance